Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
2.460
+0.020 (0.82%)
Mar 26, 2026, 11:28 AM EDT - Market open
Organogenesis Holdings Market Cap
Organogenesis Holdings has a market cap or net worth of $316.46 million as of March 26, 2026. Its market cap has decreased by -52.92% in one year.
Market Cap
316.46M
Enterprise Value
300.10M
1-Year Change
-52.92%
Ranking
Category
Stock Price
$2.46
Market Cap Chart
Since January 8, 2019, Organogenesis Holdings's market cap has decreased from $1.24B to $316.46M, a decrease of -74.40%. That is a compound annual growth rate of -17.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 313.88M | -52.25% |
| Dec 31, 2025 | 657.40M | 63.40% |
| Dec 31, 2024 | 402.32M | -25.09% |
| Dec 29, 2023 | 537.07M | 52.51% |
| Dec 30, 2022 | 352.16M | -70.37% |
| Dec 31, 2021 | 1.19B | 23.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ironwood Pharmaceuticals | 520.16M |
| Aquestive Therapeutics | 513.81M |
| Kamada | 473.03M |
| Emergent BioSolutions | 427.74M |
| Canopy Growth | 372.47M |
| Akebia Therapeutics | 372.35M |
| SIGA Technologies | 357.51M |
| Evolus | 284.31M |